Summary
Although primary intracranial neoplasms are the most common type of solid cancer in children, little is known about their etiology at the molecular genetic level. Recently, studies have shown that a class of genes known as tumor suppressors play an important role in the origin of several different types of human tumors, including those located in the central nervous system (CNS). Using a variety of techniques, selective loss of DNA sequences has been identified in tissue specimens from children with medulloblastoma, one of the most common pediatric brain tumors. The most consistent losses to date have been shown for probes located on distal chromosome arm 17p. Although the known tumor suppressor p53 is located on this chromosome, and deletion and mutation of the p53 gene are the most common genetic events in human cancers of many types, such alterations have been infrequently detected in medulloblastoma specimens. These results suggest that inactivation of another tumor suppressor gene or genes located on 17p is important in medulloblastoma tumorigenesis. Deletion of 17p has also been shown to have implications for clinical management, as the loss of DNA sequences located on this chromosome arm is strongly associated with a negative prognosis for these patients. The identification and cloning of this tumor suppressor gene or genes will aid in understanding of the pathogenesis of medulloblastoma, as well as guiding the development of novel and more effective strategies for a cure.
Similar content being viewed by others
References
Belza MG, Donaldson SS, Steinberg GK: Medulloblastoma: freedom from relapse longer than 8 years — a therapeutic cure? JNS 75: 575–582, 1991
Friend SH, Dryja TP, Weinberg RA: Oncogenes and tumor-suppressing genes. NEJM 318: 618–622, 1988
Griffen CA, Hawkins AL, Packer RJ: Chromosome abnormalities in pediatric brain tumors. Cancer Res 48: 175–180, 1988
Bigner SH, Friedman HS, Biegel JA: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30: 91–101, 1988
Thomas GA, Raffel C: Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51: 639–643, 1991
Cogen PH, Daneshvar L, Metzger AK: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8: 279–285, 1990
Biegel JA, Burk CD, Barr FG: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52: 3391–3395, 1992
James CD, He J, Carlbom E: Loss of genetic information in central nervous system tumors common to children and young adults. Genes, Chrom, Cancer 2:1990
McDonald J, Daneshvar L, Willert JR: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229–232, 1994
Knudsen AJ Jr: Mutation and cancer: Statistical study of retinoblastoma. PNAS 68: 820–823, 1971
Sparkes RS, Sparkes MC, Wilson MG: Regional assignment of genes for esterase D and retinoblastoma to chromosome band 13g14. Sci 208: 1042–1044, 1980
Cavenee WK, Dryja TP, Phillips NA: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779–784, 1983
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor, NY, 1989
Friend SH, Bernards S, Rogelj S: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 313: 101–106, 1985
Lee W-H, Shew J-Y, Hong FD: Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Nature 329: 642–645, 1987
Harbour JW Lai S-L, Whang-Peng J: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Sci 241: 353–357, 1988
Call KM, Glaser T, Ito C: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509–520, 1990
Kinzler KW, Nilbert MC, Vogelstein B: Identification of a gene located at chromosome 5821 that is mutated in colorectal cancers. Sci 251: 1366–1371, 1991
Marchuk DA, Saulino AM, Tavvakol R: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF gene product. Genomics 11: 931–940, 1991
Rouleau GA, Merel P, Lutchman M: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515–522, 1993
Miki Y, Swensen J, Shattuck-Eidens D: A strong candicate for the breast and ovarian cancer susceptibility gene BRCA1. Sci 266: 66–72, 1994
Kamb A, Gruis NA, Weaver-Feldhaus J: A cell cycle regulator potentially involved in genesis of many tumor types. Sci 264: 436–440, 1994
Soussi T, de Fromentel CC, May P: Structural aspects of the p53 protein in relation to gene evolution. Oncogenes 5: 945–952, 1990
Lamb P, Crawford L: Characterization of the human p53 gene. Mol Cell Biol 6: 1379–1385, 1986
Baker SJ, Fearon ER, Nigro JM: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Sci 244: 217–221, 1989
Nigro JM, Baker SJ, Preisinger AC: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705–708, 1989
Metzger AK, Sheffield VC, Duyk G: Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. PNAS 88: 7825–7829, 1991
Sidransky D, Mikkelsen T, Schwechheimer K: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355: 846–847, 1992
Hollstein M, Sidransky D, Vogelstein B: p53 mutations in human cancers. Sci 253: 49–54, 1991
Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes, Chrom, Cancer 10: 221–230, 1994
Cogen PH, Daneshvar L, Metzger AK: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 50: 584–589, 1992
Sheffield VC, Cox DR, Lerman LS: Attachment of a 40-base-pair G + C-rich sequence (GC clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single base-pair changes. PNAS 86: 232–236, 1989
Saylors RL, Sidransky D, Friedman HS: Infrequent p53 mutations in medulloblastoma. Cancer Res 51: 4721–4723, 1991
Adesina A, Nalbantoglu J, Cavenee WK: p53 mutation and MDM2 gene amplification are uncommon in medulloblastoma. Cancer Res 51: 5649–5651, 1994
Ohgaki H, Eibl RH, Wiestler D: p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202–6205, 1991
Coles C, Thompson AM, Elder PA: Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 336: 761–763, 1990
DiSilvestre D, Morris C, Heisterkamp N: A second hypervariable RFLP within the ABR gene. Nucl Acids Res 18: 5925, 1990
Seeger RC: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. NEJM 313: 1111–1116, 1985
Kopelson G, Linggold RM, Kleinman GM: Medulloblastoma: The identification of prognostic subgroups and implications of multimodality management. Cancer 51: 312–320, 1983
Cogen PH: Prognostic signifcance of molecular genetic markers in childhood brain tumors. Ped Neurosurg 17: 245–250, 1991–1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cogen, P.H., McDonald, J.D. Tumor suppressor genes and medulloblastoma. J Neuro-Oncol 29, 103–112 (1996). https://doi.org/10.1007/BF00165523
Issue Date:
DOI: https://doi.org/10.1007/BF00165523